Search bioRxiv⌕ Search

Biology subjects

Barry, E.

Publications and source records attributed to Barry, E..

3 recordsLinked to original sources

Genus-wide re-speciation of Corynebacterium and genomic characterisation of 87 sinus isolates resolves taxonomic conflicts and identifies four candidate novel species

Corynebacterium species are common members of the sinonasal microbiome and have shown conflicting associations with sinus health and chronic rhinosinusitis (CRS) in genus-level surveys. To better resolve the taxonomy and species-level functions of sinus corynebacteria, we generated complete long-read genome assemblies for 87 isolates, sourced from the middle meatus of 71 patients (51 with CRS, 20 healthy controls). We re-derived species boundaries de novo across the whole genus by average nucleotide identity (ANI), clustering 4,661 quality-filtered genomes retrieved from public databases and delineating higher-order species complexes. Our re-speciation assigned a species to 282 unlabelled corynebacteria, and corrected taxonomy for 266 NCBI accessions. We identified four novel candidate species from our isolate collection, and 39 public genomes fell within these species' boundaries. Whole-genome assignment reclassified 41 of our 87 isolates relative to mass-spectrometry (MALDI-TOF MS) identification, which only resolved to the species-complex level. Comparison of genome annotation characterised accessory functions that partitioned along species-complex lines, including glycogen and glycan utilisation, fatty-acid biosynthesis, cofactor (biotin and thiamine) auxotrophy, and iron-acquisition systems. Virulence and antimicrobial-resistance determinants were sparse, and the diphtheria toxin gene was universally absent. Acquired antimicrobial resistance was enriched on plasmids, whilst virulence genes were depleted from horizontally transferred compartments. Contrary to its frequent report in sinus microbiome studies, no C. tuberculostearicum genome publicly accessible via NCBI was found to be isolated from the sinonasal tract. Continued genome-level interrogation of Corynebacterium and contribution of sinus-commensals to reference databases will improve species-level understanding of the role of corynebacteria in the sinonasal microbiome.

microbiology↗

A Synthetic Microbial Therapy Rewires Antitumor Immunity Across Multiple Cancer Types

Microbial immunotherapies show promise against cancer, yet broad efficacy and mechanistic insight remain elusive. Here, we introduce SPIKE 1.0 (S1.0), a metabolically engineered bacterium that converts tryptophan into immunomodulatory hydroxyindoles via tryptophan monooxygenase to remodel the tumor microenvironment (TME). A single systemic dose of S1.0 elicited potent, durable antitumor responses across multiple murine models, including humanized mice, with minimal toxicity. S1.0 enhanced inflammatory signaling, activated innate and adaptive immunity, and promoted T cell persistence, memory, and resistance to exhaustion. It outperformed checkpoint inhibitors and synergized with chemotherapy. Multi-omics profiling revealed that S1.0 rewired amino acid metabolism in tumor-infiltrating immune cells and disrupted immunosuppressive networks. These results establish S1.0 as a scalable, cost-effective microbial immunotherapy with broad translational potential for solid tumors.

immunology↗

Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis Against Enterotoxigenic Escherichia coli Infection

BackgroundEnterotoxigenic Escherichia coli (ETEC) cause diarrheal illness in infants in the developing world and travelers to endemic countries including military personnel. ETEC infection of the host involves colonization of the small intestinal epithelium and toxin secretion leading to watery diarrhea. There is currently no vaccine licensed to prevent ETEC. CFA/I is one of the most common colonization factor antigens (CFAs). The CFA/I adhesin subunit, CfaE, is required for ETEC adhesion to host intestinal cells. Human antibodies against CfaE have potential to block colonization of ETEC and serve as an immunoprophylactic against ETEC-related diarrhea.\n\nMethodsMice transgenic for human immunoglobulin genes were immunized with CfaE to generate a panel of human monoclonal IgG1 antibodies (HuMAbs). The most potent IgG1 identified in the in vitro functional assays were selected and isotype switched to secretory IgA (sIgA) and tested in animal colonization assays via oral administration.\n\nResultsOver 300 unique anti-CfaE IgG1 HuMabs were identified. The lead IgG1 anti-CfaE HuMAbs completely inhibited hemagglutination and blocked adhesion of ETEC to Caco-2 cells. Epitope mapping studies revealed that HuMAbs recognized epitopes in the N-terminal domain of CfaE near the putative receptor binding site. Oral administration of anti-CfaE antibodies in either IgG or secretory IgA isotypes inhibited intestinal colonization in mice challenged with ETEC. A two to four log decrease of colony forming units was observed as compared to irrelevant isotype controls.\n\nConclusionsWe identified fully human monoclonal antibodies against CfaE adhesion domain that can be potentially employed as an immunoprophylaxis to prevent ETEC-related diarrhea.

microbiology↗